AllianceBernstein’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.22M | Sell |
105,937
-46,239
| -30% | -$3.34M | ﹤0.01% | 1340 |
|
|
2026
Q1 | $11.6M | Buy |
152,176
+57,868
| +61% | +$4.1M | ﹤0.01% | 1135 |
|
|
2025
Q4 | $7.16M | Buy |
94,308
+2,291
| +2% | +$166K | ﹤0.01% | 1379 |
|
|
2025
Q3 | $5.65M | Buy |
92,017
+47
| +0.1% | +$2.45K | ﹤0.01% | 1456 |
|
|
2025
Q2 | $4.49M | Sell |
91,970
-41,313
| -31% | -$1.96M | ﹤0.01% | 1524 |
|
|
2025
Q1 | $6.79M | Sell |
133,283
-228,361
| -63% | -$11.4M | ﹤0.01% | 1331 |
|
|
2024
Q4 | $16.3M | Buy |
361,644
+139,596
| +63% | +$5.97M | 0.01% | 974 |
|
|
2024
Q3 | $8.24M | Buy |
222,048
+126,398
| +132% | +$4.23M | ﹤0.01% | 1289 |
|
|
2024
Q2 | $2.92M | Sell |
95,650
-264,507
| -73% | -$8.57M | ﹤0.01% | 1746 |
|
|
2024
Q1 | $10.5M | Buy |
360,157
+6,606
| +2% | +$185K | ﹤0.01% | 1138 |
|
|
2023
Q4 | $9.74M | Buy |
353,551
+222,483
| +170% | +$5.09M | ﹤0.01% | 1169 |
|
|
2023
Q3 | $2.94M | Sell |
131,068
-4,129
| -3% | -$154K | ﹤0.01% | 1680 |
|
|
2023
Q2 | $5.5M | Sell |
135,197
-189,703
| -58% | -$9.28M | ﹤0.01% | 1394 |
|
|
2023
Q1 | $15.7M | Sell |
324,900
-23,524
| -7% | -$1.08M | 0.01% | 924 |
|
|
2022
Q4 | $13.3M | Buy |
348,424
+223,554
| +179% | +$9.29M | 0.01% | 962 |
|
|
2022
Q3 | $6.27M | Buy |
124,870
+32,320
| +35% | +$1.58M | ﹤0.01% | 1302 |
|
|
2022
Q2 | $3.71M | Hold |
92,550
| – | – | ﹤0.01% | 1596 |
|
|
2022
Q1 | $3.45M | Buy |
92,550
+200
| +0.2% | +$7.71K | ﹤0.01% | 1771 |
|
|
2021
Q4 | $3.68M | Hold |
92,350
| – | – | ﹤0.01% | 1787 |
|
|
2021
Q3 | $3.44M | Sell |
92,350
-600
| -0.6% | -$24.6K | ﹤0.01% | 1816 |
|
|
2021
Q2 | $3.93M | Sell |
92,950
-1,623,987
| -95% | -$69.6M | ﹤0.01% | 1767 |
|
|
2021
Q1 | $81.3M | Sell |
1,716,937
-56,430
| -3% | -$3.35M | 0.04% | 466 |
|
|
2020
Q4 | $108M | Buy |
1,773,367
+34,709
| +2% | +$2.05M | 0.05% | 359 |
|
|
2020
Q3 | $81.3M | Buy |
1,738,658
+74,858
| +4% | +$3.69M | 0.04% | 387 |
|
|
2020
Q2 | $84.4M | Buy |
1,663,800
+62,913
| +4% | +$3.09M | 0.05% | 362 |
|
|
2020
Q1 | $71.4M | Buy |
1,600,887
+1,519,037
| +1,856% | +$76.5M | 0.05% | 345 |
|
|
2019
Q4 | $3.93M | Buy |
81,850
+2,800
| +4% | +$119K | ﹤0.01% | 1577 |
|
|
2019
Q3 | $2.67M | Buy |
79,050
+1,100
| +1% | +$47.9K | ﹤0.01% | 1750 |
|
|
2019
Q2 | $3.51M | Buy |
77,950
+19,800
| +34% | +$782K | ﹤0.01% | 1639 |
|
|
2019
Q1 | $2.19M | Sell |
58,150
-53,800
| -48% | -$1.81M | ﹤0.01% | 1840 |
|
|
2018
Q4 | $3.84M | Buy |
111,950
+41,600
| +59% | +$1.5M | ﹤0.01% | 1442 |
|
|
2018
Q3 | $3.31M | Hold |
70,350
| – | – | ﹤0.01% | 1577 |
|
|
2018
Q2 | $2.37M | Buy |
70,350
+21,000
| +43% | +$655K | ﹤0.01% | 1795 |
|
|
2018
Q1 | $1.33M | Hold |
49,350
| – | – | ﹤0.01% | 2096 |
|
|
2017
Q4 | $823K | Hold |
49,350
| – | – | ﹤0.01% | 2375 |
|
|
2017
Q3 | $987K | Hold |
49,350
| – | – | ﹤0.01% | 2286 |
|
|
2017
Q2 | $905K | Sell |
49,350
-13,200
| -21% | -$178K | ﹤0.01% | 2338 |
|
|
2017
Q1 | $615K | Sell |
62,550
-7,100
| -10% | -$85.9K | ﹤0.01% | 2464 |
|
|
2016
Q4 | $760K | Hold |
69,650
| – | – | ﹤0.01% | 2396 |
|
|
2016
Q3 | $976K | Sell |
69,650
-6,000
| -8% | -$48.8K | ﹤0.01% | 2235 |
|
|
2016
Q2 | $531K | Buy |
75,650
+22,900
| +43% | +$168K | ﹤0.01% | 2501 |
|
|
2016
Q1 | $340K | Sell |
52,750
-1,232,735
| -96% | -$21.4M | ﹤0.01% | 2545 |
|
|
2015
Q4 | $41.6M | Buy |
1,285,485
+254,361
| +25% | +$7.49M | 0.04% | 492 |
|
|
2015
Q3 | $27.5M | Buy |
1,031,124
+248,282
| +32% | +$10.6M | 0.02% | 590 |
|
|
2015
Q2 | $37.7M | Buy |
782,842
+569,832
| +268% | +$33.2M | 0.03% | 541 |
|
|
2015
Q1 | $13M | Buy |
213,010
+179,610
| +538% | +$11M | 0.01% | 846 |
|
|
2014
Q4 | $1.73M | Buy |
33,400
+2,400
| +8% | +$106K | ﹤0.01% | 1848 |
|
|
2014
Q3 | $1.36M | Hold |
31,000
| – | – | ﹤0.01% | 1999 |
|
|
2014
Q2 | $810K | Buy |
31,000
+30,888
| +27,579% | +$661K | ﹤0.01% | 2353 |
|
|
2014
Q1 | $3K | Hold |
112
| – | – | ﹤0.01% | 3378 |
|
|
2013
Q4 | $2K | Hold |
112
| – | – | ﹤0.01% | 3245 |
|
|
2013
Q3 | $2K | Buy |
+112
| New | +$1.95K | ﹤0.01% | 3255 |
|
Other funds holding PTCT
RI
JT
AllianceBernstein's PTCT Position: Q2 2026 in Review
AllianceBernstein reduced its PTC Therapeutics (PTCT) stake by 30% in Q2 2026, selling an estimated $3.34M and leaving 105,937 shares worth $7.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1340.
AllianceBernstein first reported a position in PTCT in Q3 2013 and has held it in 52 quarters since. The position peaked at $108M in Q4 2020. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- AllianceBernstein held 105,937 shares of PTC Therapeutics worth $7.22M as of Q2 2026.
- AllianceBernstein sold 46,239 PTC Therapeutics shares in Q2 2026, an estimated $3.34M.
- PTC Therapeutics made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #1340 holding.
- AllianceBernstein first reported a position in PTC Therapeutics in Q3 2013 and has held it in 52 quarters since.
- AllianceBernstein's PTC Therapeutics position peaked at $108M in Q4 2020.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.